1. Hamanaka, Natsuki, Nakanishi, Yoshito, Mizuno, Takakazu, Ishii, Nobuya, Mio, Toshiyuki. 2019. YES1 Is a Targetable Oncogene in Cancers Harboring YES1 Gene Amplification. In Cancer research, 79, 5734-5745. doi:10.1158/0008-5472.CAN-18-3376. https://pubmed.ncbi.nlm.nih.gov/31391186/
2. Mascharak, Shamik, desJardins-Park, Heather E, Davitt, Michael F, Gurtner, Geoffrey C, Longaker, Michael T. . Preventing Engrailed-1 activation in fibroblasts yields wound regeneration without scarring. In Science (New York, N.Y.), 372, . doi:10.1126/science.aba2374. https://pubmed.ncbi.nlm.nih.gov/33888614/
3. Redin, Esther, Garrido-Martin, Eva M, Valencia, Karmele, Montuenga, Luis M, Calvo, Alfonso. 2022. YES1 Is a Druggable Oncogenic Target in SCLC. In Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 17, 1387-1403. doi:10.1016/j.jtho.2022.08.002. https://pubmed.ncbi.nlm.nih.gov/35988891/
4. Zhang, Jun, Lyu, Zhuwan, Li, Bo, Xiao, Xiao, Ma, Xiong. 2023. P4HA2 induces hepatic ductular reaction and biliary fibrosis in chronic cholestatic liver diseases. In Hepatology (Baltimore, Md.), 78, 10-25. doi:10.1097/HEP.0000000000000317. https://pubmed.ncbi.nlm.nih.gov/36799463/
5. Liu, Jia, Fan, Yongchao, Song, Ruiyu, Ma, Yuting, Zeng, Qingqi. 2023. Prostatitis No.1 traditional chinese medicine significantly exhibited anti-inflammation role on prostatitis through miR-205-5p/YES1. In Cellular and molecular biology (Noisy-le-Grand, France), 69, 270-276. doi:10.14715/cmb/2023.69.15.45. https://pubmed.ncbi.nlm.nih.gov/38279415/
6. Ying, Xiaoling, Hu, Wenyu, Huang, Yapeng, Wu, Wenqi, Ji, Weidong. 2024. A Novel tsRNA, m7G-3' tiRNA LysTTT, Promotes Bladder Cancer Malignancy Via Regulating ANXA2 Phosphorylation. In Advanced science (Weinheim, Baden-Wurttemberg, Germany), 11, e2400115. doi:10.1002/advs.202400115. https://pubmed.ncbi.nlm.nih.gov/38894581/
智鼠故事 
